Precision Syringe, Inc.
↗Omaha, United States
Precision Syringe is a medical device company that has developed a patented, index-finger-controlled syringe designed to replace the traditional thumb-plunger mechanism. This redesign aims to provide superior injection accuracy, comfort, and waste reduction, particularly for delicate procedures in ophthalmology, aesthetics, dermatology, and veterinary medicine.
The company was founded in 2019 by Dr. Donny Suh and Adrian Blake, originating from research at the University of Nebraska Medical Center. The technology is clinically proven to offer 21% greater injection accuracy and is currently preparing for FDA 510(k) submission to expand its reach into human clinical applications.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:
Industry:Medical Devices
Sub-Industry:Surgical Instruments / Injection Technology
SIZE & FINANCIALS
Employees:1-50
Founded:2019
Ownership:private
Status:operating
FUNDING
Stage:Seed
PIPELINE
Stage:Pre-commercial
Lead Drug Stage:FDA 510(k) submission preparation (Q2 2026)
Modalities:Medical Device / Injection System
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:University of Nebraska Medical Center (UNMC), UNeTech, UNeMed
COMPETITION
Position:Emerging
Competitors:Xeris Pharmaceuticals, Crossject, Windgap Medical
LEADERSHIP
Key Executives:
Adrian Blake - CEO and Co-founder
Dr. Donny Suh - Chief Medical Officer and Co-founder
Scientific Founders:Dr. Donny Suh
LINKS
Website:precisionsyringe.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Precision Syringe, Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Precision Syringe, Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.